The cumulative data from the Phase 1 study indicate that salanersen has a generally well tolerated safety profile at both the 40 mg and 80 mg doses, with most adverse events (AEs) mild to moderate in ...

Multicancer early detection (MCED) screening tests, also called “liquid biopsy” tests, are designed to detect minute quantities of circulating tumor DNA and protein biomarkers shed into the ...